Stephan Baldus
Latest contributions
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Enhancing clipping solutions for durable long-term patient outcomes
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...
Updates in transcatheter MVR
21 May 2025 – From EuroPCR 2025
This session provides a detailed overview of recent advances in transcatheter mitral valve replacement (TMVR). Examine outcomes from next-generation transcatheter heart valves, long-term clinical data from mitral valve-in-valve and valve-in-ring procedures, and explore innovative approaches including transseptal MVR with insights from global studies.
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
TAVI for pure aortic regurgitation - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on aortic regurgitation:
- An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
New iterations of self expendable valves - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on enhanced TAVI:
- An 80-year-old female with severe symptomatic aortic stenosis, a complete right bundle branch block (RBB), and preserved LV function. The operators implanted a 25 mm ACURATE Prime valve following predilation with a 22 mm balloon....
PCR Tricuspid Focus Group - Referral Meeting in Cologne
13 Jun 2024
Join your peers for this meeting on 5 November 2025 in Cologne, Germany!
Mitral valve replacement devices and techniques
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on mitral valve replacement devices and techniques. It covers various case presentations and discussions, including the treatment of mitral regurgitation with atrial fixation TMVR, mitral valve-in-valve with a novel device, transcatheter treatment of a structurally degenerated...
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement
15 May 2024 – From EuroPCR 2024
Rapid-fire - Combined mitral and tricuspid procedures
20 Nov 2023 – From PCR London Valves 2023
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Valve-in-valve - LIVE case
17 May 2023 – From EuroPCR 2023
Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function.
An Evolut Pro 26 was implanted in...
Aortic complications
17 May 2023 – From EuroPCR 2023
Enhance your understanding of managing aortic complications effectively by exploring a comprehensive series of clinical cases presented at EuroPCR. Cases studied include in particular – How to manage iatrogenic aortic dissection during TAVI- Pseudoaneurysm after TAVI, how to close the hole- Aortic dissection following TAVI and...
Treatment of multi-valve disease
29 Nov 2022 – From PCR London Valves 2022
Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...
Mitral complications
28 Nov 2022 – From PCR London Valves 2022
Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.
Mitral - Late-Breaking Trials and Innovations
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Transcatheter mitral edge intervention
17 May 2022 – From EuroPCR 2022
In this session, watch LIVE from Toulouse, France, an edge-to-edge transcatheter mitral valve repair on an 85-year-old male patient with severe primary mitral regurgitation and III NYHA shortness of breath, history of hypertension, NSTEMI in November 2019 resulting in PCI with DES on proximal and distal LADs,...
Leading clinical evidence while disrupting the mitral paradigm with clip therapy
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...
Embrace the future of mitral and tricuspid repair and replacement
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan Baldus, Georg Nickenig, Philipp Lurz Physician, Maurizio Taramasso, Dabit Arzamendi, Jorg Hausleite, Peter Ludike, Roman Pfister and Philip Raake in order to learn about the Edwards repair and replacement transcatheter portfolio, to understand how to treat with transcatheter repair and replacement technologies the...
The Edwards portfolio - Innovation in mitral and tricuspid repair & replacement
24 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to explore the clinical impact of the Edwards portfolio of transcatheter devices for MR and TR treatment and to participate in recorded case demonstrations using the Cardioband tricuspid and PASCAL repair systems.
Edge-to-edge repair for mitral regurgitation: where are we in 2020?
23 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to appreciate the importance of combined clinical and imaging assessment in determining the best treatment option for patients with severe mitral regurgitation, to reappraise the latest evidence for use of transcatheter edge-to-edge repair in this cohort and to apply this...
Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.
Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France
Annular reduction using the Cardioband system to treat tricuspid regurgitation
Tricuspid regurgitation is notoriously hard to manage, with limited medical treatment options. What are the therapeutic options available and how can the risks to patients of treatment be reduced? Patrizio Lancellotti (Belgium) talks to Stephan Baldus (Germany) and Claudius Jacobshagen (Germany) about the Cardioband tricuspid valve...
